PAM Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Description

Composition and Target Specificity

PAM Antibody, FITC conjugated consists of a polyclonal rabbit IgG raised against recombinant human PAM protein (amino acids 338-497) . The FITC fluorophore is covalently attached via primary amine groups (lysine residues) on the antibody surface . Key characteristics include:

ParameterSpecification
Target EpitopeHuman PAM catalytic domain
Host SpeciesRabbit
Conjugation Efficiency3-6 FITC molecules per antibody
Cross-ReactivityHuman (validated), Mouse (predicted)
Excitation/Emission488 nm/515 nm

Optimization and Quality Control

Effective FITC conjugation requires precise stoichiometric control to balance signal intensity and antigen-binding capacity:

Optimization Parameters

FITC:Antibody Ratio (µg/mg)OutcomesSource
10–40Low quenching but weak signal
40–80Optimal brightness/specificity balance
>160Solubility issues, signal quenching

Critical steps:

  • Sodium azide removal: Essential to prevent FITC-azide reactions

  • Chromatographic purification: DEAE Sephadex separates under/over-labeled antibodies

  • Functional validation: Parallel testing using cell staining titrations

Binding Affinity vs Labeling Index

A landmark study demonstrated :

Labeling Index (FITC/IgG)Antigen Affinity (Relative %)Non-Specific Staining
2:198%Minimal
5:172%Moderate
8:141%Severe

Higher FITC incorporation reduces binding affinity due to steric hindrance at the antigen-binding site .

Application-Specific Performance

ApplicationRecommended DilutionKey Findings
Immunofluorescence1:200–1:500 Cytosolic localization in U-2 OS cells
Western Blot0.04–0.4 µg/ml Detects 110 kDa PAM band
ELISA1:1,000–1:5,000 Linear detection range: 0.1–10 ng/ml

Stability and Handling

  • Storage: -20°C long-term in 50% glycerol/PBS

  • Light Sensitivity: 50% signal loss after 8 hr continuous light exposure

  • Freeze-Thaw Cycles: ≤3 cycles recommended

Comparative Product Analysis

VendorCatalog #Price (50 µg)Validation Data
Qtonics QA30616$190ELISA only
Biorbyt orb416881$204Human reactivity confirmed
Novus NBP2-34075$529*IHC, WB, IF validated

*Unconjugated antibody price shown for reference

Research Applications

Recent studies utilizing FITC-conjugated PAM antibodies have:

  1. Mapped PAM distribution in human cardiac tissue, showing colocalization with atrial natriuretic peptide

  2. Quantified PAM upregulation (2.7-fold) in neurodegenerative models using flow cytometry

  3. Identified pH-dependent conformational changes via Förster resonance energy transfer (FRET)

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Generally, we can ship your orders within 1-3 business days after receiving them. Delivery timelines may vary depending on the purchase method or location. Please consult your local distributors for specific delivery information.
Synonyms
AMD_HUMAN antibody; PAL antibody; PAM antibody; Pancreatic peptidylglycine alpha amidating monooxygenase antibody; Peptidyl alpha amidating enzyme antibody; Peptidyl alpha hydroxyglycine alpha amidating lyase antibody; Peptidyl-alpha-hydroxyglycine alpha-amidating lyase antibody; Peptidylamidoglycolate lyase antibody; Peptidylglycine 2 hydroxylase antibody; Peptidylglycine alpha amidating monooxygenase antibody; Peptidylglycine alpha hydroxylating monooxygenase antibody; PHM antibody
Target Names
PAM
Uniprot No.

Target Background

Function
Peptidylglycine alpha-amidating monooxygenase (PAM) is a bifunctional enzyme that catalyzes the post-translational modification of inactive peptidylglycine precursors into their corresponding bioactive alpha-amidated peptides. This terminal modification is essential in the biosynthesis of many neural and endocrine peptides. Alpha-amidation involves two sequential reactions, both catalyzed by separate catalytic domains of the enzyme. The first step, catalyzed by the peptidyl alpha-hydroxylating monooxygenase (PHM) domain, is the copper-, ascorbate-, and O2-dependent stereospecific hydroxylation (with S stereochemistry) at the alpha-carbon (C-alpha) of the C-terminal glycine of the peptidylglycine substrate. The second step, catalyzed by the peptidylglycine amidoglycolate lyase (PAL) domain, is the zinc-dependent cleavage of the N-C-alpha bond, producing the alpha-amidated peptide and glyoxylate. Similarly, PAM catalyzes the two-step conversion of an N-fatty acylglycine to a primary fatty acid amide and glyoxylate.
Gene References Into Functions
  1. A single nucleotide polymorphism (rs13175330) in the PAM gene has been associated with hypertension and insulin resistance in a Korean population. PMID: 29162152
  2. PAM's ancient ability to localize to ciliary membranes, which release bioactive ectosomes, may be linked to its capacity to accumulate in intralumenal vesicles and exosomes. PMID: 28377049
  3. Research indicates that His108 and a substrate molecule are involved in the reductive pathway, while His172 and Tyr79 play crucial roles in the catalytic pathway during the copper-centered electron transfer catalyzed by peptidylglycine monooxygenase. PMID: 26982589
  4. PAM expression is elevated in the secretory pathway of differentiated neurons. PMID: 26879543
  5. The sensitivity of Peptidylglycine alpha-Amidating Monooxygenase (PAM) to oxygen levels in neuroendocrine cells has been studied. PMID: 26296884
  6. Two missense variants in PAM, encoding p.Asp563Gly (frequency of 4.98%) and p.Ser539Trp (frequency of 0.65%), have been linked to a moderately higher risk of type 2 diabetes (OR = 1.23, P = 3.9 x 10(-10) and OR = 1.47, P = 1.7 x 10(-5), respectively). PMID: 24464100
  7. This study details the production of the catalytic core of human peptidylglycine alpha-hydroxylating monooxygenase (hPHMcc) in Escherichia coli, possessing a N-terminal fusion to thioredoxin (Trx). PMID: 22554821
  8. Data suggests that catalytic inactivation of PHM due to pH changes is accompanied by a structural shift between two protein states, involving a strong Cu-S interaction that does not involve M314. PMID: 22080626
  9. The nuclear retention of PAM mRNA is lost when expressing La proteins that lack a conserved nuclear retention element, suggesting a direct association between PAM mRNA and La protein in vivo. PMID: 16107699

Show More

Hide All

Database Links

HGNC: 8596

OMIM: 170270

KEGG: hsa:5066

STRING: 9606.ENSP00000306100

UniGene: Hs.369430

Protein Families
Peptidyl-alpha-hydroxyglycine alpha-amidating lyase family; Copper type II ascorbate-dependent monooxygenase family
Subcellular Location
Cytoplasmic vesicle, secretory vesicle membrane; Single-pass membrane protein.; [Isoform 1]: Membrane; Single-pass type I membrane protein.; [Isoform 2]: Membrane; Single-pass type I membrane protein.; [Isoform 3]: Secreted. Note=Secreted from secretory granules.; [Isoform 4]: Secreted. Note=Secreted from secretory granules.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.